
Publication
ESG and Internal Investigations: New Compliance Challenges
“ESG” refers to a set of criteria used to measure a company’s non-financial ethical and sustainability practices.
Canada | Publication | April 20, 2020 – 5 PM ET
Around the globe, pharmaceutical and medical device companies are helping in the fight of the COVID-19 pandemic. Many of these companies may have patents pertaining to technology that could be used for the benefit of the broader public during this time of crisis, such as patents on ventilators, diagnostic tests, pharmaceuticals or personal protective equipment. Governments around the globe have mechanisms in place that can mandate the use of patented inventions during a national emergency.
The reference guide provides a high-level overview of the governmental authorization provisions in Canada, the United States, France, Germany, the Netherlands, the United Kingdom, Hong Kong, China, Singapore and Australia.
Publication
“ESG” refers to a set of criteria used to measure a company’s non-financial ethical and sustainability practices.
Publication
The SFO’s Business Plan for 2025-2026 signals its intention to take centre stage in global financial crime enforcement, setting out its vision to be a “proactive, authoritative player in the global and domestic justice system”.
Publication
Managing a product recall is a challenging scenario for any company as product recalls often need to be conducted urgently and can have long-term consequences. Poorly managed recalls can have devastating effects in terms of losing customer loyalty and increased regulatory scrutiny.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2025